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OBJECTIVE: Recent evidence suggests that non-alcoholic fatty liver disease is associated with diet. Our aim was
to investigate the dietary patterns of a Brazilian population with this condition and compare them with the
recommended diet.
METHODS: A cross-sectional study was conducted on 96 non-alcoholic fatty liver disease patients before any
dietetic counseling. All patients underwent abdominal ultrasound, biochemical tests, dietary evaluations, and
anthropometric evaluations. Their food intake was assessed by a semi-quantitative food-frequency
questionnaire and 24-hour food recall.
RESULTS: The median patient age was 53 years, and 77% of the individuals were women. Most (67.7%)
participants were obese, and a large waist circumference was observed in 80.2% subjects. Almost 70% of the
participants had metabolic syndrome, and 62.3% presented evidence of either insulin resistance or overt
diabetes. Most patients (51.5, 58.5, and 61.7%, respectively) exceeded the recommendations for energy intake,
as well as total and saturated fat. All patients consumed less than the amount of recommended
monounsaturated fatty acids, and 52.1 and 76.6% of them consumed less polyunsaturated fatty acids and
fiber, respectively, than recommended. In most patients, the calcium, sodium, potassium, pyridoxine, and
vitamin C intake did not meet the recommendations, and in 10.5-15.5% of individuals, the tolerable upper limit
intake for sodium was exceeded. The patients presented a significantly high intake of meats, fats, sugars,
legumes (beans), and vegetables and a low consumption of cereals, fruits, and dairy products compared with
the recommendations.
CONCLUSIONS: Although patients with non-alcoholic fatty liver disease exhibited high energy and lipid
consumption, most of them had inadequate intake of some micronutrients. The possible role of nutrient-
deficient intake in the development of non-alcoholic fatty liver disease warrants investigation.
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& INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is currently
recognized as one of the most common causes of chronic
liver disease. It is usually associated with metabolic
syndrome (MS) (1), which is characterized by numerous
interrelated risk factors for cardiovascular disease. Obesity
and diabetes are predictors of advanced liver fibrosis and
cirrhosis in NAFLD patients (2). In the United States, the
prevalence of obesity in 2007-2008 was 32.2% among adult
men and 35.5% among adult women (3). In Brazil, 48% of
adults were overweight in 2008-2009, and approximately
12.5% of men and 16.9% of women were obese (4). Because
the prevalence of MS and obesity has increased in most
countries, the burden of NAFLD is also expected to rise (5).
Lifestyle interventions, including dietary changes and
increases in physical activity, are the first-line treatment for
NAFLD (6). It has been suggested that dietary composition
plays a role in NAFLD pathogenesis; thus, changing dietary
patterns may constitute a therapeutic resource even in the
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absence of weight reduction (7). A few recent studies have
been performed to address these questions, but their results
are quite ambiguous (8-14). Some authors note a positive
association of the increased consumption of cholesterol (8),
saturated fatty acids (8), total fatty acids (12), and a high n-
6/n-3 fatty acid ratio (12) with the presence of the disease.
On the other hand, others report an association between
NAFLD and a lower intake of polyunsaturated fats (8) and
total lipids (13). Although a positive association of carbohy-
drate intake with NAFLD (10,13) and MS (14) was
previously demonstrated, there is no consensus regarding
the relationship between the type of carbohydrate ingested
and NAFLD (9,14). Clearly, this issue warrants further
investigation.
Considering the lack of knowledge regarding the diet of
NAFLD patients in Brazil, we undertook this study to
evaluate the dietary patterns of Brazilians with NAFLD and
compare it with the Dietary Reference Intakes (15) and the
Dietary Guide for Brazilians (16).
& METHODS
A cross-sectional study was performed that included 96 of
the 114 consecutive patients diagnosed with NAFLD in the
Hepatology Clinic, University Hospital, Universidade
Federal de Minas Gerais, Belo Horizonte, Brazil, during a
two-year period (2007-2009). This institution is a reference
center of the Brazilian public health system. The inclusion
criteria comprised a diagnosis of NAFLD according to the
American Gastroenterological Association criteria (17) and a
lack of previous nutritional counseling.
The American Gastroenterological Association criteria for
NAFLD include steatosis on an abdominal ultrasound and/
or liver biopsy (performed according to clinical judgment),
the exclusion of other causes of liver disease (namely
alcohol intake .20 g/day, markers of chronic B or C
hepatitis virus infections, auto-immune hepatic disorders,
Wilson disease, hemochromatosis, and alpha-1-antitripsin
deficiency), no use of steatogenic medications within the
past six months, no exposure to hepatotoxins, and no
history of bariatric surgery (17). Alcohol use was addressed
on at least three different occasions, namely by two doctors
and by a dietician during a nutritional interview. Physical
activity was evaluated according to the patient’s informa-
tion. Considering the frequency, duration and type of
physical activity (walking for recreation, moderate activity,
or vigorous activity), our patients were classified as very
active, active, irregularly active, or sedentary (18).
MS was defined according to the National Cholesterol
Education Program’s Adult Treatment Panel III (19).
The study was approved by the local ethics committee
(ETIC 280/07), and all patients signed an informed consent
form at the time of screening for the study.
Clinical, laboratory, ultrasound and histological
investigations
All participants underwent anthropometric, laboratory
and abdominal ultrasound investigations. The anthropo-
metric data included height (m), weight (kg), body mass
index (kg/m2), and waist circumference (cm). Being over-
weight was defined as having a body mass index .25 and
,30 kg/m2, and obesity was defined as having a body mass
index $30 kg/m2 (20). A waist circumference $88 cm
(women) or $102 cm (men) was defined as high (19).
The laboratory assessment included liver biochemistry,
lipid profile, uric acid, TSH and fasting serum insulin and
glucose analyses. Insulin sensitivity was calculated using
the homeostasis model assessment (21), and insulin resis-
tance was defined by homeostasis model assessment values
$3 (22).
Fatty liver was diagnosed by abdominal ultrasound using
standardized criteria (17). The abdominal ultrasound was
performed in all subjects using the same equipment and by
the same operator, who was unaware of the clinical and
laboratory results. Some patients underwent a liver biopsy
according to clinical judgment, and the diagnosis of non-
alcoholic steatohepatitis was based on the accepted clinical-
pathological criteria (23).
Dietary assessment
Dietary intake was assessed by 24-hour food recall (24h-
FR) and a semi-quantitative food frequency questionnaire
(FFQ) adapted to the Brazilian population, which served as
a representation of the usual intake. The first method is a
suitable tool with which to evaluate food and beverage
intake within the previous 24 hours. It is easy to apply, is
inexpensive, and does not depend on the respondent’s
literacy. The semi-quantitative FFQ includes a list of more
than 80 food items and provides information on long-term
nutritional habits. It is the most commonly used method to
assess dietary intake in epidemiological studies, and its
reproducibility and validity have been investigated in the
Brazilian adult population in different studies (24,25). For
each food item, the participants indicated their average
frequency of consumption over the past year in terms of
number of specified meal sizes consumed per day/weekly/
biweekly/rarely/never. The selected frequency category for
each food item was converted into a daily intake (9). The
nutrient components of each food item were taken from the
Brazilian Food Composition Table (26).
The dietary reference values for nutrient intake by
Americans and Canadians described in the Dietary
Reference Intakes guide (15) were used to evaluate the
nutrient intake adequacy, taking into account the estimated
average intake and the adequate intake. The estimated
average intake corresponds to the amount of daily ingestion
of a nutrient estimated to satisfy the needs of half of the
individuals in a group. The adequate intake values, which
are calculated to cover or exceed the needs of all members of
a group, were used for nutrients without an available
estimated average intake. Both the estimated average intake
and the adequate intake take into consideration the
individual’s gender and age. The nutrient consumption
over the tolerable upper intake limit was determined. The
tolerable upper limit intake represents the maximum daily
amount of a nutrient that appears to be safe for the majority
of healthy people (15).
The Dietary Guide for Brazilians, which consists of
guidelines proposed by the Brazilian Ministry of Health
according to the recommendations of the World Health
Organization, was used to evaluate food intake adequacy
(16).
Groups of foods were classified according to the Dietary
Guide for Brazilians as follows: 1) cereals, roots and tubers;
2) fruits and vegetables; 3) legumes (beans and other plant
foods rich in protein); 4) milk and dairy products; 5) meat
and eggs; and 6) fats and sugars (16).
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Statistical analysis
Statistical analyses were performed using the STATA
software, version 9.0 (StataCorp LP, College Station, TX,
USA). The data are presented as frequencies, proportions,
means and standard deviations, and medians. The Shapiro-
Wilk test was used to determine whether continuous variables
were normally distributed. Continuous variables were com-
pared using the t-test (normal distribution) or the Mann-
Whitney U test (asymmetrical distribution), and proportions
were compared using the chi-square test or Fisher’s exact test,
where appropriate. To compare the nutrient intake with both
the Dietary Reference Intakes and the Dietary Guide for
Brazilians, the paired t-test or the Wilcoxon test was used for
normal or asymmetrical distributions, respectively. For all
tests, p-values ,0.05 were considered statistically significant.
& RESULTS
Characteristics of the study population
The demographic, anthropometric, and key laboratory
data of the patients are presented in Table 1. Of the 96
patients, 74 (77%) were women, and the median age was 53
years (25th and 75th percentiles = 48 and 60 years, respec-
tively). None of the participants was undernourished, four
(4.2%) had normal weight, 27 (28.1%) were overweight, and
65 (67.7%) were obese according to the body mass index
classification. A high waist circumference was observed in
77 (80.2%) individuals, namely, 15 men (68.2%) and 62
women (83.8%) (p= 0.11). Seventy-seven (80.2%) patients
were sedentary, and 19 (19.8%) were irregularly active. Six
(6.2%) individuals were smokers. Almost 70% of the study
population had MS, and 60 individuals (62.3%) presented
evidence of either insulin resistance (homeostasis model
assessment values $3) or overt diabetes. HDL cholesterol
was low in 11 (52.4%) men and 53 (75.7%) women (p= 0.05).
Other clinical features are shown in Table 2.
Approximately 20% of the subjects underwent liver
biopsy, and 13 (13.5%) of them had non-alcoholic steatohe-
patitis based on histological examination.
Adequacy of energy, macronutrient, and fiber intake
Table 3 shows the proportion of patients who met (or did
not meet) the recommendations for energy, macronutrient,
and fiber intake. According to both the 24h-FR and the semi-
quantitative FFQ, all patients had a monounsaturated fat
intake lower than the recommended amount, and more than
50% of them had a lower consumption of fiber and
polyunsaturated fats than recommended. On the other
hand, the intake of saturated fat and energy was higher
than recommended in most patients. According to the semi-
quantitative FFQ evaluation, the carbohydrate intake was
below and the total fat intake was above the recommended
values.
Adequacy of vitamin and mineral intake
The proportions of patients who met (or did not meet) the
recommended amounts of vitamins and minerals are
presented in Table 4. Both the 24h-FR and the semi-
quantitative FFQ evaluations demonstrated that almost all
patients had a calcium intake lower than the recommended
value. Most individuals had a low consumption of
potassium, vitamin C, and pyridoxine. According to the
24h-FR evaluation, 10.6% of the subjects exceeded the
tolerable upper limit intake of sodium, and according to
the FFQ evaluations, the amount of sodium consumption
was higher than recommended in 15.5% of the cases. Based
on the 24h-FR results, more than 50% of the patients had a
low intake of retinol, thiamin, magnesium, and manganese.
Food intake adequacy
The dietary data concerning food group intake are
summarized in Table 5. There were differences in the intake
of all food groups compared with the guide. The average
number of consumed meals that included cereals, fruits, and
dairy products was lower than the recommended number.
However, the number of meals consumed with legumes
(beans), vegetables, meats, fats, and sugar was higher than
recommended in the Dietary Guide for Brazilians.
& DISCUSSION
Our NAFLD patients recalled a diet richer in lipids
(specifically saturated fat and energy) and poorer in
monounsaturated fat, polyunsaturated fat, fiber, calcium,
potassium, vitamin C, and pyridoxine than the recommen-
dations. A large proportion of this population also exceeded
Table 1 - Demographic, anthropometric, and laboratory data of NAFLD patients.
Total Male Female
Parameters Median/Mean (range) Median/Mean (range) Median/Mean (range) p-value
Age (years) 54.4 (29.0; 81.0) 56.6 (36.0; 70.0) 53.7 (29.0; 72.0) 0.23a
Weight (kg) 80.4 (53.5; 130.8) 87.2 (63.0; 96.4) 78.4 (53.5; 107.5) 0.008a
BMI (kg/m2) 32.2 (23.4; 44.7) 31.0 (34.3; 31.1) 32.6 (24.4; 41.6) 0.16a
Glucose (mg/dl) 98.0 (64.0; 387.0) 94.0 (77.0; 275.0) 98.0 (64.0; 387.0) 0.48
Insulin (mU/ml) 10.1 (2.0; 23.5) 9.2 (2.0; 15.8) 10.4 (3.9; 24.0) 0.50a
HOMA 1.9 (0.5; 6.3) 1.7 (0.5; 3.7) 2.0 (0.8; 6.3) 0.60
Total cholesterol (mg/dl) 211.0 (120.0; 423.0) 187.0 (139.0; 291.0) 216.0 (120.0; 423.0) 0.03
Triglycerides (mg/dl) 173.0 (61.0; 620.0) 156.0 (61.0; 618.0) 178.0 (75.0; 620.0) 0.60
AST (x RV) 0.7 (0.3; 4.9) 0.7 (0.5; 1.8) 0.7 (0.3; 4.9) 1.00
ALT ( x RV) 0.6 (0.1; 3.3) 0.6 (0.3; 2.4) 0.6 (0.1; 3.3) 0.50
AP (x RV) 0.8 (0.2; 2.7) 0.7 (0.33; 1.1) 0.8 (0.2; 2.7) 0.30
GGT (x RV) 1.1 (0.3; 15.5) 1.0 (0.4; 7.8) 1.1 (0.3; 15.5) 0.51
Albumin (g/dl) 4.4 (3.7; 5.2) 4.5 (3.9; 5.0) 4.4 (3.7; 5.2) 0.61a
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; WC, waist circumference; HOMA, homeostasis model assessment; HDL, high-density
lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AP, alkaline phosphatase; GGT, gamma-glutamyltransferase; RV, reference
value. Means were compared using the t-test (a), and medians were compared using the Mann-Whitney test.
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the tolerable upper limit for sodium intake. These findings
correspond to a higher consumption of meats, fats, and
sugar groups, with a lower intake of cereals, fruits, and
dairy products.
Interestingly, and in contrast to the results obtained by
Cortez-Pinto et al. (12), all of our patients reported low
monounsaturated fat consumption. Most of them did not
consume any foods rich in monounsaturated fats, and less
than 12% reported olive oil intake. The relationship between
a high intake of monounsaturated fat and a good lipid
profile (reduction of low-density lipoprotein (LDL) choles-
terol and triglycerides) is well known, and the beneficial
effects of a diet rich in monounsaturated fats, particularly a
diet in which monounsaturated fats replace both saturated
fat and high amounts of carbohydrates, have been exten-
sively investigated (27). As previously reported (8), we also
observed a significantly high consumption of total and
saturated fat. The intake, corresponding to approximately
five and two times the recommendations, respectively, of
foods belonging to the ‘‘rich in fat group’’ and the ‘‘meat
group’’, certainly contributed to these findings.
Although our patients recalled recent low and adequate
long-term carbohydrate consumption, their daily intake of
meals containing the ‘‘sugar group’’ was approximately
twice the recommended intake. It is well known that a high
carbohydrate intake plays an important role in the patho-
genesis of NAFLD. Furthermore, the available evidence
suggests that the type of carbohydrate ingested may also
influence NAFLD pathogenesis (9,14,27). Foods with a high
glycemic index (e.g., sugar) increase de novo hepatic
lipogenesis, hypertriglyceridemia, hepatic insulin resis-
tance, and liver steatosis (27).
Despite their high vegetable consumption, most of our
NAFLD population reported low dietary fiber and vitamin
C intake. These findings may be due to the low intake of
fruits.
Approximately 40% of our patients had a high protein
intake, which is in agreement with the high ‘‘meat group’’
consumption. Similar results were described by Zelber-Sagi
et al. (9). Although a direct association between NAFLD and
protein intake has never been investigated, there are reports
of an association between protein intake and both insulin
resistance and diabetes (27).
The higher energy consumption in relation to the
estimated requirements, determined by both recent and
long-term assessments, most likely reflects the increased
intake of food from the ‘‘sugar group’’ and the ‘‘fat group’’.
According to some authors, patients with non-alcoholic
steatohepatitis have a higher energy intake compared with a
control group (11-14). Even in healthy people, hypercaloric
food intake could be related to alanine aminotransferase
abnormalities (28).
Calcium intake was below the recommended value in
more than 94% of our population, most likely due to the
reduced consumption of milk and dairy products. Recent
studies have suggested that calcium deficiency is related to
obesity by increasing lipogenesis and hyperinsulinemia and
inhibiting lipolysis (29). Furthermore, prospective studies
have also suggested that the intake of dairy products and
calcium reduces the risk of obesity, abdominal obesity,
diabetes, hypertension, and MS (29,30). The magnesium
intake was also below the recommended value in most of
our patients. As magnesium deficiency plays a role in
increasing insulin resistance in diabetes and MS patients
(31), we can speculate that this mineral may have some
effect on the pathogenesis of NAFLD. Although the
magnesium intake of 13.8% of our patients was above the
recommended value, the effects of excessive magnesium
consumption are known only for magnesium derived from
a pharmacological agent, not when the source is food and
water (15).
Table 2 - Clinical characteristics of NAFLD patients.
Parameters Total (%) Male (%) Female (%) p-value
Glucose intolerance or
diabetes
43.8 36.4 46.0 0.43
HOMA $3 (without diabetes) 22.5 20.0 23.0 1.00a
Insulin resistance 62.3 55.6 64.1 0.51
Hypercholesterolemia 60.4 45.5 64.9 0.10
Low HDL 69.6 52.4 75.7 0.05
Hypertriglyceridemia 63.2 57.1 64.9 0.52
Hypertension 70.8 63.6 73.0 0.40
Hyperuricemia 11.7 19.1 9.6 0.26a
Hypothyroidism 11.8 9.5 12.5 1.00a
Metabolic syndrome 69.5 52.3 74.3 0.05
NAFLD, non-alcoholic fatty liver disease. Proportions were compared
using the chi-square test or Fisher’s exact test (a).
Table 3 - Distribution of NAFLD patients by category of adequacy / inadequacy of energy, macronutrient and fiber
intake.
Parameters 24-hour food recall Food frequency questionnaire
Recommendation Intake Amount Adequate Lower Over Intake Amount Adequate Lower Over
Male Female
Median/ Mean
(range) (%) (%) (%) Median/ Mean (range) % % %
Energy EER EER 2084.8 (1116.2; 4212.1) 0.0 48.9 51.1 2507.9 (473.9; 6575.3) 0.0 32.1 67.9
Carbohydratea 50-60% TEI 270.5 (101.9; 485.7) 28.7 53.2 18.1 320.3 (49.0; 1150.2) 38.1 34.5 27.4
Protein 0.8-1.0 g/kg 75.4 (5.7; 178.2) 22.3 34.0 43.7 73.5 (21.3; 238.8) 22.6 32.1 45.2
Total fat 25-35% TEI 82.9 (32.4; 178.5) 36.2 5.3 58.5 85.1 (17.7; 203.7) 44.1 14.3 41.7
Saturated fat ,10% TEI 22.8 (7.6; 82.2) 0.0 38.3 61.7 20.9 (4.5; 64.5) 0.0 33.3 66.7
MUFAa ,20% TEI 23.2 (7.3; 45.4) 0.0 100.0 0.0 24.1 (6.2; 73.2) 0.0 100.0 0.0
PUFAa ,10% TEI 24.1 (1.8; 50.5) 0.0 52.1 47.9 25.8 (4.2; 81.5) 0.0 54.8 45.3
Fiber 20-30 g 18.2 (6.3; 56.5) 2.1 76.6 21.3 24.3 (8.0; 76.3) 0.0 53.6 46.4
NAFLD, non-alcoholic fatty liver disease; EER, energy expenditure requirements; TEI, total energy intake; MUFA, monounsaturated fat; PUFA,
polyunsaturated fat. Mean (a).
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Sodium intake was most likely underestimated in our
sample population, as we took into account only the amount
of sodium naturally contained in food but not the addition
of sodium. This limitation was due to the difficulties in
measuring the addition of sodium to foods and prepara-
tions. Nevertheless, 10.5-15.5% of our patients exceeded the
upper limit intake of sodium. It is well known that this
dietary pattern increases the risks of hypertension, cere-
brovascular disorders, and coronary heart disease (32,33).
Our NAFLD patients reported a low consumption of
antioxidant vitamins, specifically vitamins A and C. The low
intake of retinol is at least partially due to the reduced
consumption of milk (average, 0.4 meals per day) and eggs
(average, 0.04 meals per day). The low intake of fruits, as
mentioned previously, may have contributed to the low
intake of vitamin C and beta-carotene, a precursor of
vitamin A. These findings are consistent with the results
of an Italian study, which demonstrated the low consump-
tion of vitamin C by non-alcoholic steatohepatitis patients
(8). Additionally, low serum levels of retinol in NAFLD
individuals were observed in a Brazilian investigation (34).
It is well known that antioxidant vitamins have a protective
role against oxidative stress (34); therefore, the supplemen-
tation of these vitamins for treating NAFLD has been widely
investigated (35).
In this study, the high zinc, iron, copper, phosphorus,
riboflavin, and niacin consumption above the estimated
average intake and adequate intake values may be related to
the high intake of the ‘‘meat group’’ (average, 0.7 meals/
1,000 kcal). Moreover, the high consumption of beans, a
typical food in Brazilian cuisine, may also explain the high
iron and cooper intake. Contrary to our observation,
Toshimitsu et al. (14) found low zinc consumption by
NASH individuals. Additionally, in accordance with our
findings, Alla and Bonkovsky (36) demonstrated a high
intake of iron, especially heme-iron, which plays a role in
NAFLD pathogenesis by increasing oxidative stress. In this
context, some authors observed that the dietary restriction
of iron, calories, and fat is associated with a decrease in
serum aminotransferases and ferritin levels in NAFLD (37).
The data from a recent study suggest that the dietary
restriction of copper in rats may be involved in the
development of hepatic steatosis and insulin resistance
(38). In our study, in contrast, the intake of copper was
above the recommended level. However, the association
between NAFLD and copper intake has never been
investigated in humans. To our knowledge, there are no
published data relating phosphorus, niacin and riboflavin to
NAFLD.
Our study has some methodological limitations. As this
study was a cross-sectional investigation, it is not possible to
associate dietary patterns with the relative risk of NAFLD.
However, the study provides the first description of the
dietary patterns of Brazilian patients with NAFLD. In this
context, a control group would have added more informa-
tion regarding possible differences (or lack of differences) in
relation to the dietary patterns of Brazilians without
NALFD. We did not stratify our population according to
age and socioeconomic level, which are factors that could
influence dietary patterns. However, most of our subjects
(66%) were aged between 40 and 59 years, and almost all of
them (98%) were aged between 30 and 70 years; further-
more, it is well known that patients utilizing the public
health system in Brazil have low purchasing power. It
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would be better if the diagnosis of NAFLD had been
established by liver biopsy in all patients. To minimize this
limitation, we rigorously followed the American
Gastroenterology Association criteria (17). Additionally,
the possibility of both memory and reporting bias in dietary
assessment should not be ruled out, especially when
considering individuals, such as obese subjects, who have
knowledge regarding ‘‘healthy diets". The omission of
information on food consumption has been reported by
several authors (39-42). Furthermore, all methods for dietary
pattern evaluation are subject to sampling error. Thus, to
minimize these potential errors, we used two methods to
assess food intake. The FFQ questionnaire is one of the most
accepted methods for measuring food consumption in
epidemiological studies, as it is simple, fast and reliable.
In conclusion, our NAFLD patients had excessive
saturated fat, total lipid and energy intake, as well as some
nutritional deficiencies, such as monounsaturated fat,
polyunsaturated fat, calcium, vitamin C, and pyridoxine
intake deficiencies. These dietetic features could be related
to the poor long-term consumption of grains, fruits and
dairy products, as well as to the consumption of too many
meals containing legumes (beans), meats, fats and sugars,
compared with the recommendations of the Dietary Guide
for Brazilians. The possible role of each nutrient deficiency
in the development of NAFLD needs further investigation.
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